{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:13:02Z","timestamp":1783937582769,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012217","name":"Xuzhou Medical University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012217","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.ejphar.2019.03.002","type":"journal-article","created":{"date-parts":[[2019,3,2]],"date-time":"2019-03-02T01:55:33Z","timestamp":1551491733000},"page":"134-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["LncRNA FAM83H-AS1 contributes to the radioresistance, proliferation, and metastasis in ovarian cancer through stabilizing HuR protein"],"prefix":"10.1016","volume":"852","author":[{"given":"Qianru","family":"Dou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yakun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongchao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2019.03.002_bib1","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1158\/0008-5472.CAN-16-1097","article-title":"Correction: delivery of therapeutics targeting the mRNA-binding protein HuR using 3DNA nanocarriers suppresses ovarian tumor growth","volume":"76","author":"Anon","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2019.03.002_bib2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.canlet.2017.02.010","article-title":"Silencing of the mRNA-binding protein HuR increases the sensitivity of colorectal cancer cells to ionizing radiation through upregulation of caspase-2","volume":"393","author":"Badawi","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2019.03.002_bib3","first-page":"21","article-title":"Long noncoding RNA FAM83H-AS1 exerts an oncogenic role in glioma through epigenetically silencing CDKN1A","author":"Bi","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2019.03.002_bib4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3835(99)00393-6","article-title":"p53-dependent radioresistance in ovarian carcinoma cell lines","volume":"150","author":"Concin","year":"2000","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2019.03.002_bib5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.humpath.2015.09.027","article-title":"HUR mRNA expression in ovarian high-grade serous carcinoma effusions is associated with poor survival","volume":"48","author":"Davidson","year":"2016","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ejphar.2019.03.002_bib6","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1158\/1078-0432.CCR-07-0856","article-title":"Use of a combination of approaches to identify and validate relevant tumor-associated antigens and their corresponding autoantibodies in ovarian cancer patients","volume":"14","author":"Gagnon","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2019.03.002_bib7","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.18632\/oncotarget.23416","article-title":"LncRNA NEAT1 enhances the radio-resistance of cervical cancer via miR-193b-3p\/CCND1 axis","volume":"9","author":"Han","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2019.03.002_bib8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2174\/1389202916666150707155851","article-title":"Small and long non-coding RNAs: novel targets in perspective cancer therapy","volume":"16","author":"Han","year":"2015","journal-title":"Curr. Genom."},{"key":"10.1016\/j.ejphar.2019.03.002_bib9","doi-asserted-by":"crossref","first-page":"9451","DOI":"10.18632\/oncotarget.14276","article-title":"Long non-coding RNA AK058003, as a precursor of miR-15a, interacts with HuR to inhibit the expression of \u03a5-synuclein in hepatocellular carcinoma cells","volume":"8","author":"He","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2019.03.002_bib10","first-page":"493","article-title":"Missed therapeutic and prevention opportunities in women with BRCA-mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: a review of the literature","volume":"67","author":"Hoskins","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejphar.2019.03.002_bib11","unstructured":"Howlader, N.e., 2011. SEER Cancer Statistics Review, 1975-2008. http:\/\/seer.cancer.gov\/csr\/1975_2008\/."},{"issue":"Suppl 1","key":"10.1016\/j.ejphar.2019.03.002_bib12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1634\/theoncologist.7-suppl_1-20","article-title":"Nontraditional cytotoxic therapies for relapsed\/refractory multiple myeloma","volume":"7","author":"Hussein","year":"2002","journal-title":"Oncologist"},{"key":"10.1016\/j.ejphar.2019.03.002_bib13","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.1093\/nar\/gky214","article-title":"Long noncoding RNA OCC-1 suppresses cell growth through destabilizing HuR protein in colorectal cancer","volume":"46","author":"Lan","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2019.03.002_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12943-018-0870-5","article-title":"LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression","volume":"17","author":"Liang","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejphar.2019.03.002_bib15","doi-asserted-by":"crossref","first-page":"4693471","DOI":"10.1155\/2016\/4693471","article-title":"Long noncoding RNA-LET suppresses tumor growth and EMT in lung adenocarcinoma","volume":"2016","author":"Liu","year":"2016","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.ejphar.2019.03.002_bib16","first-page":"1861","article-title":"lncRNA FAM83H-AS1 is associated with the prognosis of colorectal carcinoma and promotes cell proliferation by targeting the Notch signaling pathway","volume":"15","author":"Lu","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ejphar.2019.03.002_bib17","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.bbamcr.2017.05.008","article-title":"Long non-coding RNA AC023115.3 suppresses chemoresistance of glioblastoma by reducing autophagy","volume":"1864","author":"Ma","year":"2017","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Cell Res."},{"key":"10.1016\/j.ejphar.2019.03.002_bib18","doi-asserted-by":"crossref","first-page":"64820","DOI":"10.18632\/oncotarget.11706","article-title":"HuR silencing elicits oxidative stress and DNA damage and sensitizes human triple-negative breast cancer cells to radiotherapy","volume":"7","author":"Mehta","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2019.03.002_bib19","first-page":"6076","article-title":"NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer","volume":"63","author":"Odunsi","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2019.03.002_bib20","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.7314\/APJCP.2014.15.12.4759","article-title":"Radiotherapy for ovarian cancers - redefining the role","volume":"15","author":"Rai","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.ejphar.2019.03.002_bib21","first-page":"981","article-title":"Long noncoding RNA lncARSR promotes epithelial ovarian cancer cell proliferation and invasion by association with HuR and miR-200 family","volume":"8","author":"Shu","year":"2018","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.ejphar.2019.03.002_bib22","first-page":"7","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejphar.2019.03.002_bib23","first-page":"885","article-title":"Survival and prognostic factors in patients with ovarian cancer","volume":"101","author":"Tingulstad","year":"2003","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ejphar.2019.03.002_bib24","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1159\/000452577","article-title":"Long non-coding RNA BANCR promotes endometrial cancer cell proliferation and invasion by regulating MMP2 and MMP1 via ERK\/MAPK signaling pathway","volume":"40","author":"Wang","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ejphar.2019.03.002_bib25","first-page":"1845","article-title":"Long non-coding RNA XIST exerts oncogenic functions in human glioma by targeting miR-137","volume":"9","author":"Wang","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.ejphar.2019.03.002_bib26","doi-asserted-by":"crossref","first-page":"59556","DOI":"10.18632\/oncotarget.10006","article-title":"Long non-coding RNA stabilizes the Y-box-binding protein 1 and regulates the epidermal growth factor receptor to promote lung carcinogenesis","volume":"7","author":"Wei","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2019.03.002_bib27","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/jrr\/rrs108","article-title":"Epithelial ovarian cancer: definitive radiotherapy for limited recurrence after complete remission had been achieved with aggressive front-line therapy","volume":"54","author":"Yahara","year":"2012","journal-title":"J. Radiat. Res."},{"key":"10.1016\/j.ejphar.2019.03.002_bib28","doi-asserted-by":"crossref","first-page":"22640","DOI":"10.1038\/srep22640","article-title":"Long noncoding RNA MALAT1 promotes hepatic steatosis and insulin resistance by increasing nuclear SREBP-1c protein stability","volume":"6","author":"Yan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2019.03.002_bib29","doi-asserted-by":"crossref","first-page":"7039","DOI":"10.2147\/OTT.S110055","article-title":"Identification of lncRNA FAM83H-AS1 as a novel prognostic marker in luminal subtype breast cancer","volume":"9","author":"Yang","year":"2016","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ejphar.2019.03.002_bib30","doi-asserted-by":"crossref","first-page":"42819","DOI":"10.1038\/srep42819","article-title":"Overexpression of FAM83H-AS1 indicates poor patient survival and knockdown impairs cell proliferation and invasion via MET\/EGFR signaling in lung cancer","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919301517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919301517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:27:14Z","timestamp":1757975234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299919301517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":30,"alternative-id":["S0014299919301517"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.03.002","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LncRNA FAM83H-AS1 contributes to the radioresistance, proliferation, and metastasis in ovarian cancer through stabilizing HuR protein","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}